(Q85191655)
Statements
Adjuvant dose-dense doxorubicin plus cyclophosphamide followed by dose-dense nab-paclitaxel is safe in women with early-stage breast cancer: a pilot study (English)
Joyce O'Shaughnessy
Nicholas Robert
Lea Krekow
Chris Stokoe
Alicia Clawson
14 October 2010